Vassilis Golfinopoulos

Evaluating novel agent effects in multiple‐treatments meta‐regression

Nicky J Welton, Sofia Dias, Georgia Salanti, 2010, Statistics in medicine.

Phase II part of EORTC study 26101: The sequence of bevacizumab and lomustine in patients with first recurrence of a glioblastoma.

Jacoline E. C. Bromberg, Michael Platten, Martin Bendszus, 2016 .

Lomustine and Bevacizumab in Progressive Glioblastoma

Martin Klein, Michael Platten, Martin Bendszus, 2017, The New England journal of medicine.

The dream and reality of histology agnostic cancer clinical trials

Denis Lacombe, Jan Bogaerts, Vassilis Golfinopoulos, 2014, Molecular oncology.

European perspective for effective cancer drug development

Sabine Tejpar, Denis Lacombe, Daniela Aust, 2014, Nature Reviews Clinical Oncology.

Survival and disease-progression benefits with treatment regimens for advanced colorectal cancer: a meta-analysis.

Georgia Salanti, John P A Ioannidis, Vassilis Golfinopoulos, 2007, The Lancet. Oncology.